NIAGEN BIOSCIENCE, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
NIAGEN BIOSCIENCE, INC. (NAGE) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $501.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2024-10-31
- NIAGEN BIOSCIENCE, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2024-09-30 was $164.00K, a 6.82% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2024-06-30 was $163.00K, a 5.78% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2024-03-31 was $174.00K, a 1.75% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2023-12-31 was $157.00K, a 17.80% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $677.00K, a 18.34% decline from fiscal 2022.
- NIAGEN BIOSCIENCE, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $829.00K, a 62.23% increase from fiscal 2021.
- NIAGEN BIOSCIENCE, INC. operating lease, right-of-use asset, amortization expense for fiscal 2021 was $511.00K, a 28.07% increase from fiscal 2020.
- NIAGEN BIOSCIENCE, INC. operating lease, right-of-use asset, amortization expense for fiscal 2020 was $399.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $327.00K derived: sum of 2 quarters · filed 2024-10-31 | $501.00K 10-Q · filed 2024-10-31 | $658.00K derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | $163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $337.00K 10-Q · filed 2024-08-07 | $494.00K derived: sum of 3 quarters · filed 2024-08-07 | $670.00K derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-03-31 | $174.00K 10-Q · filed 2024-05-08 | $331.00K derived: sum of 2 quarters · filed 2024-05-08 | $507.00K derived: sum of 3 quarters · filed 2024-10-31 | $680.00K derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-12-31 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $333.00K derived: sum of 2 quarters · filed 2024-10-31 | $506.00K derived: sum of 3 quarters · filed 2024-10-31 | $677.00K 10-K · filed 2024-03-06 |
| 2023-09-30 | $176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $349.00K derived: sum of 2 quarters · filed 2024-10-31 | $520.00K 10-Q · filed 2024-10-31 | $711.00K derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $344.00K 10-Q · filed 2024-08-07 | $535.00K derived: sum of 3 quarters · filed 2024-08-07 | $705.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $171.00K 10-Q · filed 2024-05-08 | $362.00K derived: sum of 2 quarters · filed 2024-05-08 | $532.00K derived: sum of 3 quarters · filed 2024-05-08 | $701.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $361.00K derived: sum of 2 quarters · filed 2024-03-06 | $530.00K derived: sum of 3 quarters · filed 2024-03-06 | $829.00K 10-K · filed 2024-03-06 |
| 2022-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $339.00K derived: sum of 2 quarters · filed 2023-11-08 | $638.00K 10-Q · filed 2023-11-08 | $764.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $468.00K 10-Q · filed 2023-08-09 | $594.00K derived: sum of 3 quarters · filed 2023-08-09 | $725.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $299.00K 10-Q · filed 2023-05-10 | $425.00K derived: sum of 2 quarters · filed 2023-05-10 | $556.00K derived: sum of 3 quarters · filed 2023-05-10 | $684.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $257.00K derived: sum of 2 quarters · filed 2023-03-08 | $385.00K derived: sum of 3 quarters · filed 2023-03-08 | $511.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | $131.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $259.00K derived: sum of 2 quarters · filed 2022-11-02 | $385.00K 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $254.00K 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $126.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $399.00K 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |